A phase I trial of topical Radezolid for the treatment of acne vulgaris.
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Radezolid (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions
- 09 Aug 2017 According to Cempra Pharmaceuticals media release, this trial is nearing completion.
- 09 Aug 2017 Status changed from planning to recruiting, according to Cempra Pharmaceuticals media release.
- 02 Mar 2017 New trial record